Salix Acquisition Of InKine Will Boost Gastrointestinal Sales Force
This article was originally published in The Pink Sheet Daily
Executive Summary
Salix announces it will pay $190 mil. in stock for InKine. The companies are publicizing the merger as creating “the largest specialty pharmaceutical company focused exclusively on gastroenterology.”